Nucleus Genomics
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $32M
Investors
- 15
About Nucleus Genomics
Nucleus Genomics Inc.Nucleus Genomics Inc. provides comprehensive genomic testing services that analyze 100% of an individual's DNA for health insights.Nucleus offers advanced genomic testing services designed to provide comprehensive insights into individual health risks and genetic predispositions. Their core product includes a proprietary DNA sequencing analysis that assesses 100% of a person's DNA, significantly exceeding the depth of sequencing offered by competitors. This service facilitates the selection of embryos for families seeking IVF and delivers actionable health information that can guide lifestyle choices and preventive care. Nucleus serves a diverse clientele, including families planning for healthy children, individuals seeking personalized health insights, and healthcare providers looking for reliable genetic data to inform patient care.Nucleus generates revenue primarily through direct-to-consumer transactions, where individuals pay for DNA testing services that provide detailed health risk assessments. Customers purchase a testing kit, which they can complete from home with a simple cheek swab. Following sample submission, customers receive a comprehensive report highlighting their genetic predispositions to various health conditions, influencing their healthcare decisions. Pricing plans and costs associated with services are transparently outlined on the company’s platform, enabling informed customer choices.Nucleus Genomics Inc. The company aims to introduce new products that enhance their genomic testing capabilities, although specific product release dates have yet to be disclosed. Additionally, Nucleus is targeting expansion into new markets, with a focus on increasing its presence in North America and Europe by the end of 2025.
Who invested in Nucleus Genomics
15 investors across 3 rounds
See all investors in Nucleus Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nucleus Genomics
Who invested in Nucleus Genomics?
Nucleus Genomics has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nucleus Genomics raised?
Nucleus Genomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nucleus Genomics last raise money?
Nucleus Genomics's most recent round on record is a Series A, in Jan 2025.
What does Nucleus Genomics do?
Nucleus Genomics is a biotechnology company.
Where is Nucleus Genomics headquartered?
Nucleus Genomics is headquartered in US.
Which VCs invest in companies like Nucleus Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nucleus Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nucleus Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.